Puma Biotechnology, Inc.
USD6.81
-0.17 (-2.44%)
CEO
Alan H. Auerbach
IPO Date
2012-04-24
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$6.96
Prev. Close
$6.98
Day Low
$6.80
Day High
$7.04
52W Low
$3.03
52W High
$7.90
Market Cap
$0.35B
Volume
0.21M
| 227,474 |
| $6.68 |
| 20 Feb 2026 | HUNT DOUGLAS M | See Remarks | A-Award | Acquired | 49,394 | $0.00 |
| 20 Feb 2026 | HUNT DOUGLAS M | See Remarks | A-Award | Acquired | 70,321 | $6.68 |
| 20 Feb 2026 | NOUGUES MAXIMO F | Chief Financial Officer | A-Award | Acquired | 46,739 | $0.00 |
| 20 Feb 2026 | NOUGUES MAXIMO F | Chief Financial Officer | A-Award | Acquired | 66,541 | $6.68 |
| 8 Jan 2026 | AUERBACH ALAN H | director, 10 percent owner, officer: President and CEO | S-Sale | Disposed | 16,938 | $5.84 |
| 8 Jan 2026 | AUERBACH ALAN H | director, 10 percent owner, officer: President and CEO | S-Sale | Disposed | 18,012 | $5.88 |
| 8 Jan 2026 | HUNT DOUGLAS M | See Remarks | S-Sale | Disposed | 3,973 | $5.84 |
| 8 Jan 2026 | HUNT DOUGLAS M | See Remarks | S-Sale | Disposed | 5,014 | $5.88 |